2018 Annual Report
From the laboratory bench to the patient’s bedside, translational outcomes are the ultimate goal of the Institute for Glycomics. Our research is yielding new insights into our understanding of the changes important to the onset and development
of cancers; and how infectious diseases evade the immune system and develop
resistance to antimicrobials. Download our 2018 Annual Report to read more about our exciting research highlights and publications that year.
2017 Annual Report
2017 was an exciting year for our Institute with a number of discoveries, from both our drug and vaccine research programs, progressing into pre-clinical and
human clinical trials. These discoveries seek to tackle some of the most challenging human diseases, including malaria, viral-induced arthritis and sepsis as detailed in this report. The Institute’s mission is to be a translational medical research institute and these trials reinforce our mission.